Stryker Set to Report Strong Third-Quarter Results

By Ben Glickman

Stryker, a leading medical technology company based in Kalamazoo, Michigan, is scheduled to announce its third-quarter financial results after the market closes on Thursday. Here’s a breakdown of what you need to know:

Net Income

According to a consensus of eight analysts polled by FactSet, Stryker is expected to report a profit of $826.3 million for the quarter, which is an increase from the $816 million earned during the same period last year.

Revenue

Analysts predict that Stryker’s sales will rise to $4.87 billion, compared to $4.48 billion reported in the previous year.

Adjusted Earnings

After accounting for certain one-time items, analysts anticipate that Stryker will post adjusted earnings of $2.43 per share, according to FactSet.

Key Factors to Watch

Procedural Trends

Following its second-quarter results, Stryker highlighted positive procedural trends that contributed to an improved sales outlook. Investors will closely monitor if these trends have continued in the third quarter.

Orthopedics Market

Stryker’s orthopedic segment has exhibited robust revenue growth, even during the pandemic, outperforming its peers. Market observers seek indications regarding the direction of the orthopedic market and whether this segment’s strong revenue growth will sustain.

Guidance Update

Analysts perceive Stryker’s guidance to be somewhat conservative. A strong quarterly performance may prompt the company to raise its outlook for the third time this year.